Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 25.03

-15.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (1255)	3/8/1998 8:44:00 PM
From: Merg	Read Replies (5) of 5736

Actually, David S. is unfortunately correct to be questioning the size of this market. Yes, bilirubin tests are done on all newborns at birth...subsequent testing is as needed. This Bili test is done on the blood samples already drawn for other purposes and a separate 'stick' is rarely needed.. When an independent bili test (and thus a blood sample) is needed it is a simple matter of poking a lancet into the baby's heel (however brutal this may seem to some observers). IMO it is unlikely that a hospital equipped to deliver babies would spend the money for this item. Perhaps there is some other disease (such as Hepatitis B pr C?) that would increase the market for this devise in a developing country like China where the disease is endemic. Any other medical people on this thread have an opinion?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next